Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David Tapolczay currently holds 840,000 shares of CONDUIT PHARMACEUTICALS INC. (CDT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Tapolczay has been a net neutral trader of CDT stock. They have purchased $0 and sold $0 worth of shares.
David Tapolczay's most recent insider trade was on Nov 18, 2024, when they sold 840,000 shares at $0.09 per share.
David Tapolczay serves as Executive at CONDUIT PHARMACEUTICALS INC. (CDT). They have executed 3 insider transactions totaling $0 over their tenure at the company.
David Tapolczay holds the position of Executive at CONDUIT PHARMACEUTICALS INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
David Tapolczay has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by David Tapolczay was on Nov 18, 2024, when they purchased $75.6K worth of CDT shares. This transaction involved 840,000 shares at $0.09 per share.
David Tapolczay currently owns 840,000 shares of CONDUIT PHARMACEUTICALS INC. (CDT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David Tapolczay's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David Tapolczay has 3 Form 4 filings on record as an insider at CONDUIT PHARMACEUTICALS INC..
Set alerts for David Tapolczay and 40,000+ other insiders.